NCT00920608View on ClinicalTrials.gov

A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis Patients

PHASE1WithdrawnINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

May 31, 2009

Study Completion Date

September 30, 2009

Conditions

Rheumatoid Arthritis

Interventions

DRUG

AZD9056

Tablets for oral use. 400 mg once daily for 7 days

DRUG

Methotrexate

Tablet for oral use.7.5 to 20 mg single dose administration at visit 2 and 3.

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY